Concepedia

Author

Anita Schmitt

Heidelberg University

Also Known As

A SCHMITT, A Schmitt, A. Schmitt, A., Schmitt, A.A. Schmitt, ANITA SCHMITT, Anita Schmitt, F Herre, Schmitt, Anita C.

223

Publications

5.8K

Citations

41

H-Index

79

Concepts

All Affiliations

Heidelberg UniversityUniversity Hospital HeidelbergUniversität UlmNational Center for Tumor DiseasesGerman Cancer Research Center
AS

About

Anita Schmitt is an author at Heidelberg University specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

36

1.7K

2

Health Sciences

4

4

185

3

Engineering

2

2

51

4

Allergy

2

2

106

5

Biomedical Engineering

1

1

49

Anita Schmitt

×

97

Publications

5K

Citations

38

H-Index

YearCitations

A vaccine targeting mutant IDH1 in newly diagnosed glioma

Michael Platten, Lukas Bunse, Antje Wick,

Nature

2021

400

Adoptive transfer and selective reconstitution of streptamer‐selected cytomegalovirus‐specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

Anita Schmitt, Torsten Tonn, Dirk H. Busch,

Transfusion

2010

216

Interleukin 1 is present in normal human epidermis.

Carl J. Hauser, J.‐H. Saurat, Anita Schmitt,

The Journal of Immunology

1986

214

Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches

Jochen Greiner, Michael Schmitt, Li Li,

Blood

2006

213

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Michael Schmitt, Anita Schmitt, Markus Rojewski,

Blood

2007

211

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir,

Nature Medicine

2023

206

Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia

Jochen Greiner, Yoko Ono, Susanne Hofmann,

Blood

2012

148

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

Jochen Greiner, Anita Schmitt, Krzysztof Giannopoulos,

Haematologica

2010

139

Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

Jochen Greiner, Mark Ringhoffer, Masanori Taniguchi,

Experimental Hematology

2002

138

mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

Jochen Greiner, Mark Ringhoffer, Masanori Taniguchi,

International Journal of Cancer

2003

133

Page 1